Course: Biostatistics for Medical Product Regulation

  • Course Home
  • Syllabus
  • Lecture Materials
  • Readings
  • Want to stay in touch?





    4 + 4 =  

Lecture Materials

You will need Adobe Reader to view these files. This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike License . Your use of this material constitutes acceptance of that license and the conditions of use of materials on this site.

The posted lecture materials represent the visual component of the multimedia lecture presentations that are available to enrolled students. Students wishing to enroll in the for-credit version, which also includes faculty interaction and assessment, may visit the Biostatistics for Medical Product Regulation page on the JHSPH Distance Education site.

» Lecture 1: Biostatistics in Medical Product Regulation: Introduction ( Day )

  • Introduce the history of medical product regulation
  • Recognize examples of public health disasters that lead to regulation
  • Describe the process of product development

» Lecture 2: Study Designs, Objectives, Hypotheses (Foulkes)

  • Visualize a variety of study designs
  • Distinguish the categories of trials
  • Identify phases by differences in objectives

» Lecture 3: Study Populations (Day)

  • Describe the study population
  • Visualize the funneling of the recruitment process
  • Distinguish to whom study results apply

» Lecture 4: Study Designs (Day)

  • Distinguish and critique various methods of randomization
  • Explore the effects of randomization
  • Characterize good allocation schemes

» Lecture 5: Comparison/Control Groups (Foulkes)

  • Explore the range of possible control groups
  • Describe the purpose of control groups
  • Distinguish and critique the use of placebos

» Lecture 6: Outcomes, Surrogates, Composite Endpoints (Day)

  • Constrast various outcome measures
  • Understand the distinction between a surrogate and clinical endpoint
  • Visualize clinical and surrogate endpoints along a causal pathway

» Lecture 7: Analysis Issues, ITT, Post-Hoc, and Subgroups (Day)

  • Introduce various analysis issues
  • Contrast choices of analysis populations, including �intention to treat�
  • Explain the limitations of subgroup and post hoc analyses

» Lecture 8: Multiplicity, Missing Data (Foulkes)

  • Characterize the analytic dilemma of missing data
  • Describe various analytic methods, their limitations and assumptions
  • Identify the occurrence of multiplicity within trials
  • Introduce various analytic approaches to multiplicity

» Lecture 9: Non-Inferiority Specification of Delta (Foulkes)

  • Introduce the concept of non-inferiority
  • Discuss the issues of assay sensitivity and "bio-creep"
  • Formulate the delta or difference that defines inferiority

» Lecture 10: Multi-Regional Studies and Bridging Studies (Day)

  • Characterize multi-regional trials
  • Explain the need for multi-regional trials
  • Distinguish when bridging studies are needed
  • Describe the inferences from bridging studies

» Lecture 11: Interim Monitoring (Foulkes)

  • Link the need for a data monitoring committee (DMC) to the nature of the study population and the risks of the intervention
  • Describe the composition of the data monitoring committee
  • Contrast the data monitoring committee with others monitoring study conduct and subject safety
  • Discuss operational aspects of interim monitoring

» Lecture 12: Course Summary and Review (Foulkes)

  • Review the complete course content
  • Compare and contrast the existing regulations
  • Forecast applications of these concepts to future medical product development